神経血管装置の世界市場分析:タイプ別(脳塞栓術および動脈瘤コイル装置、脳血管形成術およびステントシステム、神経血栓除去装置、支持装置)、治療適用別、セグメント予測、2013 – 2024

Grand View Researchが発行した調査報告書(GVIEW707583)
◆英語タイトル:Neurovascular Devices Market Analysis By Device Type (Cerebral Embolization And Aneurysm Coiling Devices, Cerebral Angioplasty And Stenting Systems, Neurothrombectomy Devices, Support Devices), By Therapeutic Applications And Segment Forecasts, 2013 - 2024
◆商品コード:GVIEW707583
◆発行会社(リサーチ会社):Grand View Research
◆発行日:2016年11月7日
◆ページ数:97
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single UserUSD4,950 ⇒換算¥544,500見積依頼/購入/質問フォーム
Multi UserUSD7,950 ⇒換算¥874,500見積依頼/購入/質問フォーム
Global/corporate LicenseUSD9,950 ⇒換算¥1,094,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGrand View Research社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。Grand View Research社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートでは、神経血管装置の世界市場について調査・分析し、神経血管装置の世界市場動向、神経血管装置の世界市場規模、市場予測、セグメント別神経血管装置市場分析、主要地域別市場規模、競争状況、関連企業情報などを含め、以下の構成でお届け致します。
【レポートの概要】

The global neurovascular device market was valued at USD 1.62 billion in the year 2015 and is expected to reach a value of USD 2.92 billion by 2024, growing at a CAGR of 6.5% according to a new report by Grand View Research, Inc.
Key factors driving the market growth include increase in patients suffering from cerebral vascular disorders mandating assistance of neurovascular devices such as cerebral embolization and aneurysm coils, implementation of advanced technological platforms in this field, and the favorable reimbursement policies across established markets such as the U.S., Canada, U.K., Germany, and Japan.

The market is segmented on the basis of device type and respective therapeutic applications. The embolization coils are widely employed in the treatments of strokes and cerebral aneurysms. They are responsible for majority of market share in the device type segment. According to World Health Organization (WHO), strokes are the leading cause of disability and third cause of death across the world. Stroke therapeutic application segment accounts for the largest market as compared to others. In addition, according to the American Heart Association, nearly 5% of the population is currently suffering from the cerebral aneurysms. Aneurysms can cause moderate to severe brain damage depending upon the condition. Therefore, their treatment is contributing to the increased demand of these platforms.

The embolization and aneurysms coiling devices are minimally invasive and are employed in effectively treating the aneurysms. Several diseases can be treated with the help of a single coil however; the unusual cerebral aneurysms require several expensive coils. Due to the efficacy, the volume for these procedures has increased over the years. This trend will continue over the forecast period, thereby rendering the leading position for this segment in terms of revenue share. The stenting systems possess the potential to address complex natured aneurysms, which were untreatable in the past. Hence, the cerebral angioplasty and stenting systems will exhibit an impressive growth pattern during the forecast period.

Moreover, Stryker Corporation is a key leader in the neurovascular device market, owing to the strategic acquisition of complete neurovascular portfolio of Boston Scientific Corporation in the year 2010. The other notable players in this industry include Abbott Laboratories, W.L. Gore & Associates, Inc., Micorport Scientific Corporation, and Terumo Corporation.

Further Key Findings from the Study Suggest:

Rising incidence of cerebral vascular disorders such as strokes (both ischemic and hemorrhagic), arterial stenosis, and brain aneurysms are primarily responsible for the high demand for neurovascular diseases.

On the basis of types, the market is segmented into embolization and aneurysms coils, stenting systems, neurothrombectomy and support devices. Among these, embolic coils are widely used owing to the safety and efficacy, followed by the stenting systems.

According to the therapeutic application of the device type, stroke accounts for the largest market share, reason being the leading cause of disability and third cause of deaths worldwide.

In addition, the rising geriatric population and increased life expectancy are causing an increase in the target patient population.

【レポートの目次】

Table of Content

Chapter 1 Methodology & Scope
1.1 Research Methodology
1.2 Research Scope & Assumptions
1.3 List of Data Sources
Chapter 2 Executive Summary
Chapter 3 Market Summary
Chapter 4 Market Variables, Trends& Scope
4.1 Market segmentation & scope
4.1.1 Market Driver Analysis
4.1.2 Market Restraint Analysis
4.2 Penetration & growth prospect mapping
4.3 Neurovascular Devices Market – SWOT Analysis, By Factor (political & legal, economic and technological)
4.4 Industry Analysis – Porter’s
Chapter 5 Market Categorization 1: Device Type Estimates & Trend Analysis
5.1 Neurovascular Devices market: Device Type movement analysis
5.2 Cerebral Embolization and Aneurysm Coiling Devices
5.2.1 Cerebral Embolization and Aneurysm Coiling Devices market, 2013 – 2024 (USD Million)
5.2.1.1 Embolic Coils market, 2013 – 2024 (USD Million)
5.2.1.2 Flow Diversion Devices market, 2013 – 2024 (USD Million)
5.2.1.3 Liquid Embolic Agents market, 2013 – 2024 (USD Million)
5.3 Cerebral Angioplasty and Stenting Systems
5.3.1 Cerebral Angioplasty and Stenting Systems market, 2013 – 2024 (USD Million)
5.3.1.1 Carotid Artery Stents market, 2013 – 2024 (USD Million)
5.3.1.2 Embolic Protection Systems (Distal Filter Devices, Balloon Occlusion Devices) market, 2013 – 2024 (USD Million)
5.4 Neurothrombectomy Devices
5.4.1 Neurothrombectomy Devices market, 2013 – 2024 (USD Million)
5.4.1.1 Clot retrieval Devices market, 2013 – 2024 (USD Million)
5.4.1.2 Suction Devices market, 2013 – 2024 (USD Million)
5.4.1.3 Vascular Snares market, 2013 – 2024 (USD Million)
5.5 Support Devices
5.5.1 Support Devices market, 2013 – 2024 (USD Million)
5.5.1.1 Micro catheters market, 2013 – 2024 (USD Million)
5.5.1.2 Micro guidewires market, 2013 – 2024 (USD Million)
Chapter 6 Market Categorization 2: Therapeutic Applications Estimates & Trend Analysis
6.1 Neurovascular Devices market: Therapeutic Applications movement analysis
6.2 Stroke
6.2.1 Stroke market, 2013 – 2024 (USD Million)
6.3 Cerebral Artery Stenosis
6.3.1 Cerebral Artery Stenosis market, 2013 – 2024 (USD Million)
6.4 Cerebral Aneurysm
6.4.1 Cerebral Aneurysm market, 2013 – 2024 (USD Million)
6.5 Others
6.5.1 Others market, 2013 – 2024 (USD Million)
Chapter 7 Market Categorization 3: Regional Estimates & Trend Analysis, by Treatment Type, and End-Use
7.1 Neurovascular Devices market share by region, 2013 & 2024
7.2 North America
7.2.1 U.S.
7.2.2 Canada
7.3 Europe
7.3.1 UK
7.3.2 Germany
7.4 Asia Pacific
7.4.1 Japan
7.4.2 China
7.4.3 India
7.5 Latin America
7.5.1 Mexico
7.5.2 Brazil
7.6 MEA
7.6.1 South Africa
Chapter 8 Competitive Landscape
8.1 Strategy framework
8.2 Company Profiles
8.2.1 Abbott Laboratories
8.2.1.1 Company Overview
8.2.1.2 Financial Performance
8.2.1.3 Product Benchmarking
8.2.1.4 Strategic Initiatives
8.2.2 W. L. Gore & Associates, Inc.
8.2.2.1 Company Overview
8.2.2.2 Financial Performance
8.2.2.3 Product Benchmarking
8.2.2.4 Strategic Initiatives
8.2.3 Johnson and Johnson
8.2.3.1 Company Overview
8.2.3.2 Financial Performance
8.2.3.3 Product Benchmarking
8.2.3.4 Strategic Initiatives
8.2.4 Medtronic
8.2.4.1 Company Overview
8.2.4.2 Financial Performance
8.2.4.3 Product Benchmarking
8.2.4.4 Strategic Initiatives
8.2.5 Merit Medical Systems, Inc.
8.2.5.1 Company Overview
8.2.5.2 Financial Performance
8.2.5.3 Product Benchmarking
8.2.5.4 Strategic Initiatives
8.2.6 Microport Scientific Corporation
8.2.6.1 Company Overview
8.2.6.2 Financial Performance
8.2.6.3 Product Benchmarking
8.2.6.4 Strategic Initiatives
8.2.7 Penumbra, Inc.
8.2.7.1 Company Overview
8.2.7.2 Financial Performance
8.2.7.3 Product Benchmarking
8.2.7.4 Strategic Initiatives
8.2.8 Stryker Corporation
8.2.8.1 Company Overview
8.2.8.2 Financial Performance
8.2.8.3 Product Benchmarking
8.2.8.4 Strategic Initiatives
8.2.9 Terumo Corporation
8.2.9.1 Company Overview
8.2.9.2 Financial Performance
8.2.9.3 Product Benchmarking
8.2.9.4 Strategic Initiatives

List of Figures

FIG. 1 Market summary
FIG. 2 Market trends & outlook
FIG. 3 Neurovascular Devices : Market Segmentation
FIG. 4 Market driver relevance analysis (Current & future impact)
FIG. 5 Market restraint analysis (Current & future impact)
FIG. 6 Penetration & growth prospect mapping
FIG. 7 SWOT Analysis, By Factor (political & legal, economic and technological)
FIG. 8 Neurovascular Devices Porter’s analysis
FIG. 9 Neurovascular Devices market Devices type outlook key takeaways
FIG. 10 Neurovascular Devices market: Devices type movement analysis
FIG. 11 Global Cerebral Embolization and Aneurysm Coiling Devices market, 2013 - 2024 (USD Million)
FIG. 12 Global Embolic Coils market, 2013 - 2024 (USD Million)
FIG. 13 Global Flow Diversion Devices market, 2013 - 2024 (USD Million)
FIG. 14 Global Liquid Embolic Agents market, 2013 - 2024 (USD Million)
FIG. 15 Global Cerebral Angioplasty and Stenting Systems market, 2013 - 2024 (USD Million)
FIG. 16 Global Carotid Artery Stents market, 2013 - 2024 (USD Million)
FIG. 17 Global Embolic Protection Systems (Distal Filter Devices, Balloon Occlusion Devices) market, 2013 - 2024 (USD Million)
FIG. 18 Global Neurothrombectomy Devices market, 2013 - 2024 (USD Million)
FIG. 19 Global Clot retrieval Devices market, 2013 - 2024 (USD Million)
FIG. 20 Global Suction Devices market, 2013 - 2024 (USD Million)
FIG. 21 Global Vascular Snares market, 2013 - 2024 (USD Million)
FIG. 22 Global Support Devices market, 2013 - 2024 (USD Million)
FIG. 23 Global Micro catheters market, 2013 - 2024 (USD Million)
FIG. 24 Global Micro guidewires market, 2013 - 2024 (USD Million)
FIG. 25 Neurovascular Devices market Therapeutic applications outlook key takeaways
FIG. 26 Neurovascular Devices market: Therapeutic applications movement analysis
FIG. 27 Global Stroke market, 2013 - 2024 (USD Million)
FIG. 28 Global Cerebral Artery Stenosis market, 2013 - 2024 (USD Million)
FIG. 29 Global Cerebral Aneurysm market, 2013 - 2024 (USD Million)
FIG. 30 Global Others market, 2013 - 2024 (USD Million)
FIG. 31 Regional market place: Key takeaways
FIG. 32 Regional outlook, 2015 & 2024
FIG. 33 Strategy framework
FIG. 34 Participant categorization

List of Tables

TABLE 1 Country share estimation
TABLE 2 North America Neurovascular Device market, by Devices type, 2013 - 2024 (USD Million)
TABLE 3 North America Neurovascular Device market, by Therapeutic applications, 2013 - 2024 (USD Million)
TABLE 4 U.S. Neurovascular Devices market, by Device type, 2013 - 2024 (USD Million)
TABLE 5 U.S. Neurovascular Devices market, by Therapeutic applications, 2013 - 2024 (USD Million)
TABLE 6 Canada Neurovascular Devices market, by Device type, 2013 - 2024 (USD Million)
TABLE 7 Canada Neurovascular Devices market, by Therapeutic applications, 2013 - 2024 (USD Million)
TABLE 8 Europe Neurovascular Devices market, by Device type, 2013 - 2024 (USD Million)
TABLE 9 Europe Neurovascular Devices market, by Therapeutic applications, 2013 - 2024 (USD Million)
TABLE 10 UK Neurovascular Devices market, by Device type, 2013 - 2024 (USD Million)
TABLE 11 UK Neurovascular Devices market, by Therapeutic applications, 2013 - 2024 (USD Million)
TABLE 12 Germany Neurovascular Devices market, by Device type, 2013 - 2024 (USD Million)
TABLE 13 Germany Neurovascular Devices market, by Therapeutic applications, 2013 - 2024 (USD Million)
TABLE 14 Asia Pacific Neurovascular Devices market, by Device type, 2013 - 2024 (USD Million)
TABLE 15 Asia Pacific Neurovascular Devices market, by Therapeutic applications, 2013 - 2024 (USD Million)
TABLE 16 Japan Neurovascular Devices market, by Device type, 2013 - 2024 (USD Million)
TABLE 17 Japan Neurovascular Devices market, by Therapeutic applications, 2013 - 2024 (USD Million)
TABLE 18 China Neurovascular Devices market, by Device type, 2013 - 2024 (USD Million)
TABLE 19 China Neurovascular Devices market, by Therapeutic applications, 2013 - 2024 (USD Million)
TABLE 20 India Neurovascular Devices market, by Device type, 2013 - 2024 (USD Million)
TABLE 21 India Neurovascular Devices market, by Therapeutic applications, 2013 - 2024 (USD Million)
TABLE 22 Latin America Neurovascular Devices market, by Device type, 2013 - 2024 (USD Million)
TABLE 23 Latin America Neurovascular Devices market, by Therapeutic applications, 2013 - 2024 (USD Million)
TABLE 24 Mexico Neurovascular Devices market, by Devices type, 2013 - 2024 (USD Million)
TABLE 25 Mexico Neurovascular Devices market, by Therapeutic applications, 2013 - 2024 (USD Million)
TABLE 26 Brazil Neurovascular Devices market, by Device type, 2013 - 2024 (USD Million)
TABLE 27 Brazil Neurovascular Devices market, by Therapeutic applications, 2013 - 2024 (USD Million)
TABLE 28 MEA Neurovascular Devices market, by Device type, 2013 - 2024 (USD Million)
TABLE 29 MEA Neurovascular Devices market, by Therapeutic applications, 2013 - 2024 (USD Million)
TABLE 30 South Africa Neurovascular Devices market, by Device type, 2013 - 2024 (USD Million)
TABLE 31 South Africa Neurovascular Devices market, by Therapeutic applications, 2013 - 2024 (USD Million)

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 神経血管装置の世界市場分析:タイプ別(脳塞栓術および動脈瘤コイル装置、脳血管形成術およびステントシステム、神経血栓除去装置、支持装置)、治療適用別、セグメント予測、2013 – 2024(Neurovascular Devices Market Analysis By Device Type (Cerebral Embolization And Aneurysm Coiling Devices, Cerebral Angioplasty And Stenting Systems, Neurothrombectomy Devices, Support Devices), By Therapeutic Applications And Segment Forecasts, 2013 - 2024)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆